HLA-dependent autoantibodies against post-translationally modified collagen type II in type 1 diabetes mellitus

Diabetologia

Volumn 56, Issue 3, 2013, Pages 563-572

  Strollo, R ^a,b   Rizzo, P ^a,c   Spoletini, M ^d   Landy, R ^a   Hughes, C ^a   Ponchel, F ^e   Napoli, N ^b   Palermo, A ^b   Buzzetti, R ^d   Pozzilli, P ^b,f   Nissim, A ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e UNIVERSITY OF LEEDS   (United Kingdom)

^f QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Collagen type II; Post translational modification; Reactive oxygen species; Rheumatoid arthritis

Indexed keywords

COLLAGEN TYPE 2; EPITOPE; HEMOGLOBIN A1C; HLA ANTIBODY; REACTIVE OXYGEN METABOLITE;

ADULT; ALLELE; ANTIGEN BINDING; ARTICLE; AUTOIMMUNITY; CHILD; CONTROLLED STUDY; FEMALE; GENOTYPE; GLUCOSE HOMEOSTASIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PROCESSING; RHEUMATOID ARTHRITIS; SCHOOL CHILD; SEROCONVERSION;

ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BLOOD GLUCOSE; COLLAGEN TYPE II; DIABETES MELLITUS, TYPE 1; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENOTYPE; HLA-DRB1 CHAINS; HUMANS; OXIDATIVE STRESS; PROTEIN PROCESSING, POST-TRANSLATIONAL; REACTIVE OXYGEN SPECIES;

EID: 84878370123     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-012-2780-1     Document Type: Article

References (39)

1. Bluestone JA, Herold K, Eisenbarth G (2010) Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 464:1293-1300
2. Concannon P, Rich SS, Nepom GT (2009) Genetics of type 1A diabetes. N Engl J Med 360:1646-1654
3. Petrone A, Battelino T, Krzisnik C et al (2002) Similar incidence of type 1 diabetes in two ethnically different populations (Italy and Slovenia) is sustained by similar HLA susceptible/protective haplotype frequencies. Tissue Antigens 60:244-253
4. Thomson G, Valdes AM, Noble JA et al (2007) Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: a meta-analysis. Tissue Antigens 70:110-127
5. Pihoker C, Gilliam LK, Hampe CS, Lernmark A (2005) Autoantibodies in diabetes. Diabetes 54(Suppl 2):S52-S61
6. West IC (2000) Radicals and oxidative stress in diabetes. Diabet Med 17:171-180
7. Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-820
8. Griffiths HR (2008) Is the generation of neo-antigenic determinants by free radicals central to the development of autoimmune rheumatoid disease? Autoimmun Rev 7:544-549
9. Trigwell SM, Radford PM, Page SR et al (2001) Islet glutamic acid decarboxylase modified by reactive oxygen species is recognized by antibodies from patients with type 1 diabetes mellitus. Clin Exp Immunol 126:242-249
10. Khan MW, Banga K, Mashal SN, Khan WA (2011) Detection of autoantibodies against reactive oxygen species modified glutamic acid decarboxylase-65 in type 1 diabetes associated complications. BMC Immunol 12:19
11. Khan MW, Sherwani S, Khan WA, Ali R (2009) Characterization of hydroxyl radical modified GAD65: a potential autoantigen in type 1 diabetes. Autoimmunity 42:150-158
12. Szkudelski T (2001) The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 50:537-546
13. Kim WUCM, Jung YO, Min SY, Park SW, Min DJ, Yoon JH, Kim HY (2004) Type II collagen autoimmunity in rheumatoid arthritis. Am J Med Sci 327:202-211
14. Kim WUYW, Park W, Kang YM, Kim SI, Park JH, Lee SS, Joo YS, Min JK, Hong YS, Lee SH, Park SH, Cho CS, Kim HY (2000) IgG antibodies to type II collagen reflect inflammatory activity in patients with rheumatoid arthritis. J Rheumatol 3:575-581
15. Nissim A, Winyard PG, Corrigall V et al (2005) Generation of neoantigenic epitopes after posttranslational modification of type II collagen by factors present within the inflamed joint. Arthritis Rheum 52:3829-3838
16. Cooper GS, Bynum ML, Somers EC (2009) Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. J Autoimmun 33:197-207
17. Liao KP, Gunnarsson M, Kallberg H et al (2009) Specific association of type 1 diabetes mellitus with anti-cyclic citrullinated peptide-positive rheumatoid arthritis. Arthritis Rheum 60:653-660
18. Newton JL, Harney SM, Wordsworth BP, Brown MA (2004) A review of the MHC genetics of rheumatoid arthritis. Genes Immun 5:151-157
19. Petrone A, Giorgi G, Galgani A et al (2005) CT60 single nucleotide polymorphisms of the cytotoxic T-lymphocyte-associated antigen-4 gene region is associated with Graves' disease in an Italian population. Thyroid 15:232-238
20. Imboden JB (2009) The immunopathogenesis of rheumatoid arthritis. Annu Rev Pathol 4:417-434
21. Bland JM, Altman DG (2000) Statistics notes. The odds ratio. BMJ 320:1468
22. Rosario PW, Reis JS, Borges MA et al (2005) Extrapancreatic autoimmunity in patients with latent autoimmune diabetes of adults. Diabetes Care 28:496-497
23. Murao S, Kondo S, Ohashi J et al (2008) Anti-thyroid peroxidase antibody, IA-2 antibody, and fasting C-peptide levels predict beta cell failure in patients with latent autoimmune diabetes in adults (LADA)-a 5-year follow-up of the Ehime study. Diabetes Res Clin Pract 80:114-121
24. Triolo TM, Armstrong TK, McFann K et al (2011) Additional autoimmune disease found in 33% of patients at type 1 diabetes onset. Diabetes Care 34:1211-1213
25. Nielen MM, van Schaardenburg D, Reesink HW et al (2004) Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 50:380-386
26. Baeten D, Peene I, Union A et al (2001) Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium: relevance to antifilaggrin autoantibodies. Arthritis Rheum 44:2255-2262
27. Backlund J, Carlsen S, Hoger T et al (2002) Predominant selection of T cells specific for the glycosylated collagen type II epitope (263-270) in humanized transgenic mice and in rheumatoid arthritis. Proc Natl Acad Sci USA 99:9960-9965
28. Mannering SI, Harrison LC, Williamson NA et al (2005) The insulin A-chain epitope recognized by human T cells is posttranslationally modified. J Exp Med 202:1191-1197
29. Brorsson C, Tue Hansen N, Bergholdt R, Brunak S, Pociot F (2010) The type 1 diabetes-HLA susceptibility interactome - identification of HLA genotype-specific disease genes for type 1 diabetes. PLoS One 5:e9576
30. Queisser MA, Yao D, Geisler S et al (2010) Hyperglycemia impairs proteasome function by methylglyoxal. Diabetes 59:670-678
31. Irigoyen P, Lee AT, Wener MH et al (2005) Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles. Arthritis Rheum 52:3813-3818
32. Verpoort KN, van Gaalen FA, van der Helm-van Mil AH et al (2005) Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis. Arthritis Rheum 52:3058-3062
33. Vay D, Vidali M, Allochis G et al (2000) Antibodies against advanced glycation end product Nepsilon-(carboxymethyl)lysine in healthy controls and diabetic patients. Diabetologia 43:1385-1388
34. Festa A, Kopp HP, Schernthaner G, Menzel EJ (1998) Autoantibodies to oxidised low density lipoproteins in IDDM are inversely related to metabolic control and microvascular complications. Diabetologia 41:350-356
35. Doyle HA, Mamula MJ (2002) Posttranslational protein modifications: new flavors in the menu of autoantigens. Curr Opin Rheumatol 14:244-249
36. Lipponen K, Gombos Z, Kiviniemi M et al (2010) Effect of HLA class I and class II alleles on progression from autoantibody positivity to overt type 1 diabetes in children with risk-associated class II genotypes. Diabetes 59:3253-3256
37. Knip M, Korhonen S, Kulmala P et al (2010) Prediction of type 1 diabetes in the general population. Diabetes Care 33:1206-1212
38. Barera G, Bonfanti R, Viscardi M et al (2002) Occurrence of celiac disease after onset of type 1 diabetes: a 6-year prospective longitudinal study. Pediatrics 109:833-838
39. Beyan H, Riese H, Hawa MI et al (2012) Glycotoxin and autoantibodies are additive environmentally determined predictors of type 1 diabetes: a twin and population study. Diabetes 61:1192-1198